These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop. Bykerk VP; Lie E; Bartlett SJ; Alten R; Boonen A; Christensen R; Furst DE; Hewlett S; Leong AL; Lyddiatt A; March L; May JE; Montie P; Orbai AM; Pohl C; Scholte Voshaar M; Woodworth T; Bingham CO; Choy EH J Rheumatol; 2014 Apr; 41(4):799-809. PubMed ID: 24584927 [TBL] [Abstract][Full Text] [Related]
14. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7. Kirwan JR; Hewlett SE; Heiberg T; Hughes RA; Carr M; Hehir M; Kvien TK; Minnock P; Newman SP; Quest EM; Taal E; Wale J J Rheumatol; 2005 Nov; 32(11):2250-6. PubMed ID: 16265712 [TBL] [Abstract][Full Text] [Related]
15. Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group. Alten R; Pohl C; Choy EH; Christensen R; Furst DE; Hewlett SE; Leong A; May JE; Sanderson TC; Strand V; Woodworth TG; Bingham CO; J Rheumatol; 2011 Aug; 38(8):1745-50. PubMed ID: 21807796 [TBL] [Abstract][Full Text] [Related]
16. Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity. Tugwell P; Boers M; D'Agostino MA; Beaton D; Boonen A; Bingham CO; Choy E; Conaghan PG; Dougados M; Duarte C; Furst DE; Guillemin F; Gossec L; Heiberg T; van der Heijde DM; Hewlett S; Kirwan JR; Kvien TK; Landewé RB; Mease PJ; Østergaard M; Simon L; Singh JA; Strand V; Wells G J Rheumatol; 2014 May; 41(5):1000-4. PubMed ID: 24692531 [TBL] [Abstract][Full Text] [Related]
17. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis. Coates LC; FitzGerald O; Merola JF; Smolen J; van Mens LJJ; Bertheussen H; Boehncke WH; Callis Duffin K; Campbell W; de Wit M; Gladman D; Gottlieb A; James J; Kavanaugh A; Kristensen LE; Kvien TK; Luger T; McHugh N; Mease P; Nash P; Ogdie A; Rosen CF; Strand V; Tillett W; Veale DJ; Helliwell PS Arthritis Rheumatol; 2018 Mar; 70(3):345-355. PubMed ID: 29193765 [TBL] [Abstract][Full Text] [Related]
18. Advancing Stiffness Measurement in Rheumatic Disease: Report from the Stiffness Special Interest Group at OMERACT 2018. Craig ET; Orbai AM; Mackie S; Bartlett SJ; Bingham CO; Goodman S; Hill C; Holt R; Leong A; Karyekar C; Leung YY; Richards P; Halls S J Rheumatol; 2019 Oct; 46(10):1374-1378. PubMed ID: 30770511 [TBL] [Abstract][Full Text] [Related]
19. Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group. Petkovic J; Barton JL; Flurey C; Goel N; Bartels CM; Barnabe C; de Wit MPT; Lyddiatt A; Lacaille D; Welch V; Boonen A; Shea B; Christensen R; Maxwell LJ; Campbell W; Jull J; Toupin-April K; Singh JA; Goldsmith CH; Sreih AG; Pohl C; Hofstetter C; Beaton DE; Buchbinder R; Guillemin F; Tugwell PS J Rheumatol; 2017 Nov; 44(11):1727-1733. PubMed ID: 28202740 [TBL] [Abstract][Full Text] [Related]
20. Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology. Beaton DE; Maxwell LJ; Shea BJ; Wells GA; Boers M; Grosskleg S; Bingham CO; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March LM; Simon LS; Singh JA; Strand V; Tugwell P J Rheumatol; 2019 Aug; 46(8):1028-1035. PubMed ID: 30709952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]